The Current Ratio as of December 2024 (TTM) for Fennec Pharmaceuticals Inc. (FENC) is 7.80

According to Fennec Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.80. This represents a change of 18.55% compared to the average of 6.58 of the last 4 quarters.

Fennec Pharmaceuticals Inc. (FENC) Historical Current Ratio (quarterly & annually)

How has FENC Current Ratio performed in the past?

The mean historical Current Ratio of Fennec Pharmaceuticals Inc. over the last ten years is 8.71. The current 7.80 Current Ratio has changed 8.85% with respect to the historical average. Over the past ten years (40 quarters), FENC's Current Ratio was at its highest in in the June 2021 quarter at 33.11. The Current Ratio was at its lowest in in the December 2014 quarter at 1.35.

Fennec Pharmaceuticals Inc. (FENC) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Fennec Pharmaceuticals Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Fennec Pharmaceuticals Inc. (FENC) Average Current Ratio

How has FENC Current Ratio performed in the past?

The current Current Ratio of Fennec Pharmaceuticals Inc. (FENC) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Fennec Pharmaceuticals Inc. (FENC) Current Ratio vs. Peers

How is FENC’s Current Ratio compared to its peers?

Fennec Pharmaceuticals Inc.’s Current Ratio is less than Molecular Partners AG (14.33), less than MediciNova, Inc. (16.66), greater than Anebulo Pharmaceuticals, Inc. (3.45), greater than Champions Oncology, Inc. (0.75), less than Cyteir Therapeutics, Inc. (21.89), less than Keros Therapeutics, Inc. (19.03), less than Janux Therapeutics, Inc. (38.80), less than Edgewise Therapeutics, Inc. (26.35), greater than Harmony Biosciences Holdings, Inc. (3.24), less than Ikena Oncology, Inc. (0), less than Aerovate Therapeutics, Inc. (15.32), less than Eliem Therapeutics, Inc. (8.78), less than Decibel Therapeutics, Inc. (0), greater than Olema Pharmaceuticals, Inc. (4.81), greater than Disc Medicine, Inc. (7.10), less than Larimar Therapeutics, Inc. (19.36), less than Orchestra BioMed Holdings, Inc. (13.10), greater than null (4.23),

Build a custom stock screener for Fennec Pharmaceuticals Inc. (FENC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fennec Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fennec Pharmaceuticals Inc. (FENC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fennec Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.